Crohn's Disease Clinical Trials in Fayetteville, North Carolina

4 studies are recruiting for crohn's disease in Fayetteville, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Cross Creek Medical Clinic, Fayetteville, North Carolina
    Locations
    225 in total
    Run by
    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

    See if you can join NCT06226883 on ClinicalTrials.gov

  2. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight. The maximum duration of this study is up to 6…

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Coastal Research Institute - Fayetteville, Fayetteville, North Carolina
    Locations
    183 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06937099 on ClinicalTrials.gov

  3. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Cross Creek Medical Clinic-Site Number: 8400057, Fayetteville, North Carolina
    Locations
    301 in total
    Run by
    Sanofi

    See if you can join NCT07184931 on ClinicalTrials.gov

  4. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Cross Creek Medical Clinic-Site Number: 8400057, Fayetteville, North Carolina
    Locations
    35 in total
    Run by
    Sanofi

    See if you can join NCT07184944 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.